Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 1/16/2001)
Latest financial report
10-K - Q4 2024 - Feb 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.3 % -11.7%
Quick Ratio 27.8 % -21.8%
Debt-to-equity 554 % +15.8%
Return On Equity -25.3 % -258%
Return On Assets -3.97 % -206%
Operating Margin -1.83 % -167%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.13B shares +1.14%
Entity Public Float 18.3B USD +119%
Common Stock, Value, Issued 58M USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 1.13B shares +1.07%
Weighted Average Number of Shares Outstanding, Diluted 1.13B shares +1.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.5B USD +4.41%
Selling and Marketing Expense 2.54B USD +8.78%
General and Administrative Expense 1.16B USD -0.09%
Operating Income (Loss) -303M USD -170%
Nonoperating Income (Expense) -981M USD +7.19%
Income Tax Expense (Benefit) 676M USD -27.5%
Net Income (Loss) Attributable to Parent -1.64B USD -193%
Earnings Per Share, Basic -1.45 USD/shares -190%
Earnings Per Share, Diluted -1.45 USD/shares -190%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.3B USD +2.29%
Accounts Receivable, after Allowance for Credit Loss, Current 3.06B USD -10.2%
Inventory, Net 3.01B USD -25.2%
Other Assets, Current 409M USD -18.8%
Assets, Current 12.6B USD +0.54%
Deferred Income Tax Assets, Net 1.8B USD -0.72%
Property, Plant and Equipment, Net 4.58B USD -20.3%
Operating Lease, Right-of-Use Asset 367M USD -7.56%
Goodwill 15.1B USD -11.8%
Other Assets, Noncurrent 462M USD -1.7%
Assets 39.3B USD -9.55%
Accounts Payable, Current 158M USD +46.3%
Employee-related Liabilities, Current 624M USD +2.13%
Liabilities, Current 12.8B USD +4.48%
Operating Lease, Liability, Noncurrent 296M USD -7.5%
Other Liabilities, Noncurrent 4.03B USD +0.22%
Liabilities 33.6B USD -4.94%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.15B USD -16.7%
Retained Earnings (Accumulated Deficit) -15.2B USD -12.1%
Stockholders' Equity Attributable to Parent 5.37B USD -28.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.38B USD -33.8%
Liabilities and Equity 39.3B USD -9.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.25B USD -8.85%
Net Cash Provided by (Used in) Financing Activities -1.79B USD +6.38%
Net Cash Provided by (Used in) Investing Activities 792M USD -18.2%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 1.24B shares +1.06%
Common Stock, Par or Stated Value Per Share 0.1 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 74M USD -81.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.3B USD +2.26%
Deferred Tax Assets, Valuation Allowance 2.02B USD -33%
Deferred Tax Assets, Gross 1.8B USD -0.72%
Operating Lease, Liability 383M USD -8.15%
Payments to Acquire Property, Plant, and Equipment 119M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.09B USD -399%
Lessee, Operating Lease, Liability, to be Paid 495M USD -0.2%
Property, Plant and Equipment, Gross 8.99B USD -21%
Operating Lease, Liability, Current 296M USD -7.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 102M USD +4.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 120M USD +3.45%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81M USD +1.25%
Unrecognized Tax Benefits 449M USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 57M USD -8.07%
Additional Paid in Capital 27.8B USD -0.16%
Amortization of Intangible Assets 588M USD -4.55%